5 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly's retatrutide shows promising results in weight loss trials, driving stock gains and regulatory anticipation
Peptides are gaining broad attention across regulatory, skincare, and investment sectors following recent FDA scrutiny and market analysis.
Lilly, Johnson & Johnson and AbbVie stocks reach unprecedented levels as investors shift from tech to healthcare.
Sangamo Therapeutics' bankruptcy filing and asset sale to Lilly and Astellas is making waves in the biotech industry.
Speculation swirls around a 79-year-old patient who received an experimental weight loss drug, with former President Trump as the suspected recipient.